Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,102 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparative effectiveness of palliative chemotherapy versus neoadjuvant chemotherapy followed by radical cystectomy versus cystectomy followed by adjuvant chemotherapy versus cystectomy for regional node-positive bladder cancer: A retrospective analysis: KCSG GU 17-03.
Bae WK, Lee HJ, Park SH, Kim JH, Kim HJ, Maeng CH, Park I, Sohn BS, Kim JA, Lee KH, Lim DH, Chang H, Kim SM, Kim HY, Song H, Lim S, Byun JH, Jung HA. Bae WK, et al. Among authors: park i, park sh. Cancer Med. 2019 Sep;8(12):5431-5437. doi: 10.1002/cam4.2446. Epub 2019 Jul 29. Cancer Med. 2019. PMID: 31353788 Free PMC article.
Response evaluation criteria in solid tumors response of the primary lesion in metastatic renal cell carcinomas treated with sunitinib: does the primary lesion have to be regarded as a target lesion?
Park I, Park K, Park S, Ahn Y, Ahn JH, Choi HJ, Jeong IG, Song C, Hong JH, Kim CS, Ahn H, Lee JL. Park I, et al. Among authors: park s, park k. Clin Genitourin Cancer. 2013 Sep;11(3):276-82. doi: 10.1016/j.clgc.2012.12.005. Epub 2013 Jan 17. Clin Genitourin Cancer. 2013. PMID: 23332873
A phase II study of neoadjuvant docetaxel, oxaliplatin, and S-1 (DOS) chemotherapy followed by surgery and adjuvant S-1 chemotherapy in potentially resectable gastric or gastroesophageal junction adenocarcinoma.
Park I, Ryu MH, Choi YH, Kang HJ, Yook JH, Park YS, Kim HJ, Jung HY, Lee GH, Kim KC, Kim BS, Kang YK. Park I, et al. Among authors: park ys. Cancer Chemother Pharmacol. 2013 Oct;72(4):815-23. doi: 10.1007/s00280-013-2257-z. Epub 2013 Aug 7. Cancer Chemother Pharmacol. 2013. PMID: 23921575 Clinical Trial.
A randomized phase II study of weekly docetaxel/cisplatin versus weekly docetaxel/oxaliplatin as first-line therapy for patients with advanced gastric cancer.
Kim YS, Sym SJ, Park SH, Park I, Hong J, Ahn HK, Park J, Cho EK, Lee WK, Chung M, Lee JH, Shin DB. Kim YS, et al. Among authors: park i, park sh, park j. Cancer Chemother Pharmacol. 2014 Jan;73(1):163-9. doi: 10.1007/s00280-013-2334-3. Epub 2013 Nov 8. Cancer Chemother Pharmacol. 2014. PMID: 24202666 Clinical Trial.
Randomized Phase II Study of Pemetrexed Versus Gefitinib in Previously Treated Patients with Advanced Non-small Cell Lung Cancer.
Kim YS, Cho EK, Woo HS, Hong J, Ahn HK, Park I, Sym SJ, Kyung SY, Kang SM, Park JW, Jeong SH, Park J, Lee JH, Shin DB. Kim YS, et al. Among authors: park jw, park i, park j. Cancer Res Treat. 2016 Jan;48(1):80-7. doi: 10.4143/crt.2014.307. Epub 2015 Mar 2. Cancer Res Treat. 2016. PMID: 25761488 Free PMC article. Clinical Trial.
6,102 results